Why low-cost ketamine is still inaccessible to many with severe depression
A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for treatment-resistant depression.
Oct 23, 2023
0
0
A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for treatment-resistant depression.
Oct 23, 2023
0
0
Scientists are setting out to collect genetic material from 500,000 people of African ancestry to create what they believe will be the world's largest database of genomic information from the population.
Oct 18, 2023
0
0
A high proportion of patients with newly diagnosed vitiligo do not receive any treatment, according to a study recently published in Dermatology and Therapy.
Oct 17, 2023
0
0
Three out of four American adults say prescription drug prices are unaffordable, and nearly a third admit to not taking prescribed medications due to cost, according to a recent poll conducted by the Kaiser Family Foundation. ...
Oct 10, 2023
0
1
Tezepelumab is associated with a reduction in occlusive mucus plugs versus placebo in adults with uncontrolled asthma, according to a study published in the October issue of NEJM Evidence.
Sep 29, 2023
0
1
Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines.
Sep 28, 2023
0
5
Researchers in the University of Delaware College of Health Sciences Department of Medical and Molecular Sciences are playing a pivotal role on the global health stage as they investigate the most common sexually transmitted ...
Sep 19, 2023
0
1
For adults with refractory or unexplained chronic cough, gefapixant leads to modest improvement in cough frequency, severity, and quality of life, according to a review published online Sept. 11 in the Journal of the American ...
Sep 11, 2023
0
1
Researchers have discovered a new avenue of cell death in Alzheimer's disease and vascular dementia.
Sep 5, 2023
0
208
The public sector should pay if EU demands efficient removal of pharmaceuticals from wastewaters, according to researchers at the Center for Antibiotic Research, CARe, at the University of Gothenburg. Their argumentation ...
Sep 5, 2023
0
1